These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15655320)

  • 21. Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal disease.
    Fukui H; Hara S; Hashimoto Y; Horiuchi T; Ikezoe M; Itami N; Kawabe M; Kawanishi H; Kimura H; Nakamoto Y; Nakayama M; Ono M; Ota K; Shinoda T; Suga T; Ueda T; Fujishima M; Maeba T; Yamashita A; Yoshino Y; Watanabe S;
    Ther Apher Dial; 2004 Feb; 8(1):56-61. PubMed ID: 15128021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of iodinated contrast agents on residual renal function in PD patients.
    Moranne O; Willoteaux S; Pagniez D; Dequiedt P; Boulanger E
    Nephrol Dial Transplant; 2006 Apr; 21(4):1040-5. PubMed ID: 16352623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dialysis modality and cardiac disease in chronic kidney insufficiency].
    Grzegorzewska AE
    Pol Merkur Lekarski; 2006 Apr; 20(118):453-6. PubMed ID: 16886575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
    Arogundade FA; Ishola DA; Sanusi AA; Akinsola A
    Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Case in Which Renal Function and Peritoneal Function Were Maintained for Ten Years by Proactive Combination Therapy with Peritoneal Dialysis and Hemodialysis.
    Ueda A; Nagai K; Saito C; Yamagata K
    Adv Perit Dial; 2018 Nov; 34(2018):42-46. PubMed ID: 30480536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of residual renal function loss in peritoneal dialysis: is previous renal transplantation a risk factor?
    Bernardo A; Fonseca I; Rodrigues A; Carvalho MJ; Cabrita A
    Adv Perit Dial; 2009; 25():110-4. PubMed ID: 19886330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the peritoneal membrane durable indefinitely?
    Hallett MD; Charlton B; Farrell PC
    Adv Perit Dial; 1990; 6():197-201. PubMed ID: 1982808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing dialysis modality for end-stage renal disease in developing countries: a survey of Filipino nephrologists.
    Cruz DN; Troidle L; Danguilan R; Padilla B; Frando L; Sebastian E; Sy-Lim A; Luz V; Finkelstein F
    Blood Purif; 2011; 32(2):117-23. PubMed ID: 21540587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of furosemide in patients on peritoneal dialysis.
    Flinn A; Ledger S; Blake P
    CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study.
    Haag-Weber M; Krämer R; Haake R; Islam MS; Prischl F; Haug U; Nabut JL; Deppisch R;
    Nephrol Dial Transplant; 2010 Jul; 25(7):2288-96. PubMed ID: 20197284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical benefit of preserving residual renal function in patients after initiation of dialysis.
    Kuno T; Matsumoto K
    Blood Purif; 2004; 22 Suppl 2():67-71. PubMed ID: 15655327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to start the late referred ESRD patient urgently on chronic APD.
    Povlsen JV; Ivarsen P
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii56-9. PubMed ID: 16825263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal dialysis in acute renal failure.
    Gabriel DP; Nascimento GV; Caramori JT; Martim LC; Barretti P; Balbi AL
    Ren Fail; 2006; 28(6):451-6. PubMed ID: 16928612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of angiotensin converting enzyme inhibitors on potassium homeostasis in dialysis patients with and without residual renal function.
    Garthwaite E; Bhandari S
    Artif Organs; 2009 Aug; 33(8):641-7. PubMed ID: 19624582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of healthy start peritoneal dialysis on the evolution of residual renal function and nutrition parameters.
    Van Biesen W; Dequidt C; Vanholder R; Lameire N
    Adv Perit Dial; 2002; 18():44-8. PubMed ID: 12402585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An integrative description of dialysis adequacy indices for different treatment modalities and schedules of dialysis.
    Debowska M; Waniewski J; Lindholm B
    Artif Organs; 2007 Jan; 31(1):61-9. PubMed ID: 17209962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrafiltration volume by once-weekly hemodialysis is a predictor of technique survival of combination therapy with peritoneal dialysis and hemodialysis.
    Tanaka M; Ishibashi Y; Hamasaki Y; Kamijo Y; Idei M; Nishi T; Takeda M; Nonaka H; Nangaku M; Mise N
    Ther Apher Dial; 2021 Feb; 25(1):82-87. PubMed ID: 32383342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effects of combined therapy with peritoneal dialysis and hemodialysis.
    Kawanishi H; Moriishi M
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S126-9. PubMed ID: 17556290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of extracellular volume expansion in long-term peritoneal dialysis.
    Tzamaloukas AH
    Adv Perit Dial; 2005; 21():106-11. PubMed ID: 16686297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What influences patient choice of treatment modality at the pre-dialysis stage?
    Chanouzas D; Ng KP; Fallouh B; Baharani J
    Nephrol Dial Transplant; 2012 Apr; 27(4):1542-7. PubMed ID: 21865216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.